ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03587740 |
Recruitment Status :
Active, not recruiting
First Posted : July 16, 2018
Last Update Posted : September 6, 2023
|
Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Susan G. Komen Breast Cancer Foundation
Gateway for Cancer Research
Information provided by (Responsible Party):
Rachel Freedman, MD, MPH, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | August 30, 2026 |
Estimated Study Completion Date : | August 30, 2029 |